- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Dixie Brands Obtains Patent for Cannabinoid Delivery Method
Dixie Brands’ subsidiary has received approval for a patent covering the development of unique cannabinoid delivery methods.
A Colorado-based cannabis company has obtained a US patent through its subsidiary.
On Thursday (December 5), Dixie Brands (CSE:DIXI.U,OTCQX:DXBRF) confirmed its subsidiary Aceso Wellness will obtain a patent from the US Patent and Trademark Office for a set of delivery formats for cannabinoids with nutrients in an effervescent powder or a liquid form.
Chuck Smith, president and CEO of Dixie Brands, said in a press release that while the patent will help to protect the intellectual property (IP) of the firm, the move also signals “the continued legitimization and normalization of the cannabis industry.”
According to Dixie Brands, Aceso has already commercialized the technology in question.
Shares of the public firm received a boost to start the trading session on Thursday. The company opened at C$0.23, representing a 2.3 percent jump in value from its previous closing price.
Dixie Brands Director of Science Jay Denniston said the approval for the patent application, dubbed “Cannabinoid Emulsion Product and Process for Making the Same,” represents the culmination of a three year process for the company.
Aceso’s patent covers a range of formats and formulations that include a variety of neutraceutical compositions, such as cannabinoids, supplements and vitamins.
Dixie announced a new discovery in its own development of infused beverages in July of this year. Smith explained to the Investing News Network at the time that the beverages will be water-soluble drink additives containing THC.
“In the beverage space, if you drink alcohol you know what happens when you have a couple of glasses of wine … and we want to be able to mimic that experience as close as possible,” Smith said.
Interest for the cannabis-infused beverages market has increased as beverage firms have thrown their support in for the development of these drinks.
Alcohol makers such as Constellation Brands (NYSE:STZ), Molson Coors (NYSE:TAP,TSX:TAP), AB InBev (NYSE:BUD) and Moosehead Breweries have all formed partnerships with cannabis producers to participate in the creation of new-generation marijuana drinks.
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.Â